CTCs were present in 70.9% of HCC patients. The presence of mesenchymal CTCs was significantly correlated with high AFP levels, multiple tumors, advanced TNM and BCLC stage, presence of embolus or micro-embolus, and earlier recurrence. Ou et al., 2018 (57). The gene discussed is AFP; the disease is hepatocellular carcinoma.